GEODE CAPITAL MANAGEMENT, LLC

Position in ABPO — Abpro Holdings, Inc.

CIK 1214717 BOSTON, MA

Position in ABPO

as of Dec 31, 2025 · filed Feb 9, 2026 Compact

Position Value

$45,619

+$45,619 QoQ

Shares Held

10,785

-47.9% QoQ

Ownership

0.183%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$45,619	10,785	—	Shares	Defined	2026-02-09
2024-09-30 ACAB	—	20,710	0.0%	Shares	Defined	2024-11-12
2024-06-30 ACAB	—	20,710	0.0%	Shares	Defined	2024-08-09
2024-03-31 ACAB	—	20,710	0.0%	Shares	Defined	2024-05-13
2023-12-31 ACAB	—	20,710	-4.8%	Shares	Defined	2024-02-13
2023-09-30 ACAB	—	21,746	-20.9%	Shares	Defined	2023-11-13
2023-06-30 ACAB	—	27,493	0.0%	Shares	Defined	2023-08-11
2023-03-31 ACAB	—	27,493	0.0%	Shares	Defined	2023-05-15
2022-12-31 ACAB	—	27,493	0.0%	Shares	Defined	2023-02-13
2022-09-30 ACAB	—	27,493	0.0%	Shares	Defined	2022-11-14
2022-06-30 ACAB	—	27,493	—	Shares	Defined	2022-08-12
No filing history on record for this holder in this stock.